ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-10
DOI
10.1038/srep36447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
- (2015) Michael Y. Choi et al. Clinical Lymphoma Myeloma & Leukemia
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
- (2015) Yanchun Liu et al. PLoS One
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- US lung cancer trends by histologic type
- (2014) Denise Riedel Lewis et al. CANCER
- Beyond EGFR TKI in EGFR-mutant Non-Small Cell Lung Cancer patients: Main challenges still to be overcome
- (2014) J. Remon et al. CANCER TREATMENT REVIEWS
- The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapy
- (2014) Mohammad Hojjat-Farsangi et al. SEMINARS IN CANCER BIOLOGY
- ROR1, an embryonic protein with an emerging role in cancer biology
- (2014) Nicholas Borcherding et al. Protein & Cell
- Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
- (2013) M. Beau-Faller et al. ANNALS OF ONCOLOGY
- Mechanisms of resistance to EGFR targeted therapies
- (2013) Gorjan Hrustanovic et al. CANCER BIOLOGY & THERAPY
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma
- (2013) Jacques Cadranel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?
- (2013) Fadi S. Farhat et al. Therapeutic Advances in Medical Oncology
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Biomarkers for the lung cancer diagnosis and their advances in proteomics
- (2011) Hye-Jin Sung et al. BMB Reports
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Baskar et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started